SUMMARY. We used standard microelectrode techniques to determine the effects of SC-72-14, a monoclonal antibody to the fast sodium channel, on the transmembrane potentials and Vm,, of canine cardiac Purkinje fibers, and to study the interactions of the monoclonal antibody with lidocaine. SC-72-14 was prepared with receptor-rich membrane fragments of homogenized eel electroplax as the antigen. It reduced V,,^ in a concentration-dependent fashion, and depressed membrane responsiveness, as well. These effects were attributable specifically to SC-72-14, and not to other substances in the vehicle. At slow rates of stimulation, the actions of SC-72-14 and lidocaine on V^ equaled the sum of their effects, administered alone. These results are consistent with the interpretation that SC-72-14 and the local anesthetic did not compete for the same binding site. In contrast, at fast stimulation rates, the use-dependent blocking effects of lidocaine were suppressed by SC-72-14. The basis for the interference with the use-dependent action of lidocaine is not readily apparent, but may be the result of SC-72-14-induced changes in channel state, receptor affinity for drug, or the availability of ionized drug molecules. These possibilities all await further testing. (Circ Res 57: 354-361 1985) 
IN STUDIES of the fast sodium channels of excitable tissues, drugs or toxins usually are used to modify the fast inward current (e.g., Kao, 1966; Narahashi, 1974; Cahalan, 1980; Catterall, 1980; Sigworth and Neher, 1980) . The effects of these agents on the transmembrane potential and the action potential upstroke appear to result from their binding to a particular site or sites in the channel, resulting in modulation of Na + entry. Lidocaine, which decreases the fast inward current in nerve, skeletal muscle, and heart (Strichartz, 1976; Hille, 1977a Hille, , 1977b Schwartz et al., 1977; Bean et al., 1983 ) is also stated to modify repolarization in the heart through its actions on the sodium window current (Colatsky, 1982) , although earlier studies suggested it might modify steady state potassium conductance (Arnsdorf and Bigger, 1972; Weld and Bigger, 1976) . Tetrodotoxin, through its action on the fast inward current (Kao, 1966; Narahashi, 1974) modifies only phase 0 depolarization in nerve. However, through its action on the Na + channel, it also modifies the window current and repolarization in cardiac fibers (Attwell et al., 1979; Colatsky and Gadsby, 1980; Gintant et al., 1983b) .
Another approach to the study of ion channels has been the use of polyclonal or monoclonal antibodies that are prepared against antigenic determinants of the channels (e.g., Ellisman and Levinson, 1982; Moore et al., 1982; Fritz and Brockes, 1983; Casadei et al., 1983) . Thus, most Na + channel antibodies have been prepared with solubilized channels from eel electroplax or mammalian skeletal muscle, and have not demonstrated biological activity (Ellisman and Levinson, 1982; Moore et al., 1982; Fritz and Brockes, 1983) . Recently, monoclonal antibodies have been prepared with receptor-rich membrane fragments of homogenized eel electroplax (Grunhagen et al., 1981) . One such antibody, SC-72-14, was physiologically active, depressing the compound action potential of rat optic nerve and sciatic nerve (Meiri et al., 1984) . On voltage clamp analysis, it depressed the fast inward sodium current in a concentration-dependent manner without affecting leakage curent or repolarizing current (Meiri et al., unpublished data) .
Our purpose in this study was to test this antibody on mammalian cardiac fibers. As shall be demonstrated, SC-72-14 modifies the Purkinje fiber action potential in a manner different from that of the local anesthetic, lidocaine, the effect of which is altered by the antibody.
and pinned these to the Silastic-covered floor of a Ludte chamber that held a volume of 5 ml. The Tyrode's solution in the chamber was gassed as above and had a pH of approximately 7.3 and P02 of 250-300 mm Hg. The temperature of the Tyrode's solution was maintained at 37°C with a water jacket. The tissue chamber was connected to ground with a 3M KCl-Ag-AgCl junction. Use of this chamber permitted us to stop flow while maintaining temperature, pH, and Pch. This was essential to conserve SC-72-14, which was available in limited quantities.
The fiber bundles were stimulated with a bipolar silver electrode, insulated to the tip with Teflon. Square pulses (2-3 msec and 1.25 times threshold) were delivered, using previously described pulse and waveform generators and stimulus isolation units (Morikawa and Rosen, 1984) .
We impaled the preparations with 3 M KG-filled glass capillary electrodes that had tip resistances of 10-20 Mil. The electrodes were connected via an Ag-AgCl bar to an amplifier with high input impedence and capacitance neutralization. The signal was displayed on an oscilloscope and on a strip chart recorder.
The equipment was calibrated as previously described, and the following measurements were made on all preparations (Morikawa and Rosen, 1984) : the maximum diastolic potential, the activation voltage (the level of membrane potential at which the action potential was initiated), the action potential amplitude, and action potential duration to 50% and full repolarization (APD50 and APD100, respectively). In addition, we used previously described techniques to differentiate and record the maximum rate of rise of phase 0 (V^) (Rosen et al., 1973) . The system used was linear over a range of 100-900 V/sec.
Membrane responsiveness curves were prepared as previously described (Morikawa and Rosen, 1984) ; fibers were driven at a basic cycle length (BCL) of 1 second, and after every eight driven action potentials, a premature stimulus was delivered, using a 2-to 3-msec square pulse with an amplitude two times threshold. This was moved progressively earlieT during phases 4 and 3 until it failed to elicit a premature response. We then plotted the rate of rise of each premature action potential as a function of its activation voltage.
In all experiments, after making an impalement, we then stopped flow into the tissue bath. When stable transmembrane potentials had been recorded for 30-60 minutes, we then added stock solutions of SC-72-14 or lidocaine (dissolved in Tyrode's solution) directly to the tissue bath in quantities sufficient to attain the desired concentration. Lidocaine attained a steady state effect within 20 minutes, and the antibody, within 5-20 minutes. To wash out the lidocaine or antibody, we perfused the tissue bath with Tyrode's solution at a rate of 8 ml/minute for 3 minutes; the flow was again stopped and the fiber permitted to reequilibrate.
In experiments on rate-dependent effects of the antibody and of lidocaine, we used three microelectrodes as described previously (Morikawa and Rosen, 1984) . Two were placed intracellularly, quite close to one another. One was used to record voltage, and the second to inject current, such that for each measurement of V^ we could ensure the maintenance of the same membrane potential at the recording site that had existed during control. The third electrode was extracellular and close to the other two. This was used to monitor ' O ' potential. A WPI S7071A electrometer was used in these experiments. We drove the preparations at long cycle lengths (1.0-1.5 seconds) to estimate the occurrence and magnitude of tonic block (i.e., the extent of depression of Vm, when there is a low frequency of stimulation) and at short cycle lengths (0.5-0.4 seconds) to document the occurrence of usedependent block (i.e., the modulation of drug-induced reduction of V^ by a change in rate of initiation of electrical activity) (Courtney, 1975; Strichartz, 1976; Hille, 1977; Hondeghem and Katzung, 1977; Hondeghem and Katzung, 1980; Gintant et al., 1983a) . As previously described, we found that a drive cycle length of 1 second was sufficient to demonstrate tonic block with lidocaine, and cycle lengths of 0.4-0.5 second demonstrated lidocaine's use-dependent actions (Morikawa and Rosen, 1984) .
As has been noted previously, the measurement of Vm*x is an indirect means for studying the drug-receptor interaction and its effects on the fast inward current (see Grant et al., 1984) ; no attempt was made at a quantitative determination of effects on the sodium channel.
For statistical testing, we used a paired f-test when appropriate, and a nested analysis of variance to test differences between curves. In the latter instance, when the F-value so indicated, we used Scheffe's test to compare individual data points (Snedecor and Cochran; 1967) . All • values are expressed as mean ± SE.
Immunological Agents
SC-72-14 was prepared by Meiri and associates as previously described (Meiri et al., 1984) . The electroplax of Electrophorus electricus was homogenized, centrifuged, and subfractionated on a sucrose gradient (Grunhagen et al., 1981) . The fragments used for immunization contained 3.2 mg protein/ml and 4.3 pmol tetrodotoxin binding sites/mg protein (Meiri et al., 1984) . Initially, 0.3 ml of this fraction, diluted 1:10 in phosphate-buffered saline (PBS) was injected with complete Freund's adjuvant (at a 1:1 ratio) into the footpad of CD 2 Fi mice. A second injection was given 2 weeks later, and 1 month thereafter a booster dose of 0.4 ml was given ip. Three days later, the mice were killed and their spleen cells were fused with nonproducing plasmacytoma cells (NSO/1 derived from NS1/1 Ag4.1) as described by Galfre and Milstein (1981) . The hybrid lines then were grown in hypoxanthine/thymidine/aminopterin-selected medium, and screening for those cultures secreting antibodies was done by radioimmunoassay, by immunofluorescent staining of the node of Ranvier, and by the ability of the antibody to block the compound action potential of rat optic nerve (Meiri et al., 1984; Meiri et al., unpublished data) . Those hybridomas selected for further study were cloned and recloned on soft agar, and the isolated clones then were grown in tissue culture and in ascitic fluid in CD 2 Fi mice. The immunoglobulin fraction was collected after precipitation in 40-50% ammonium sulfate, and the antibody class was determined by the Ouchterlony double-diffusion method.
The monoclonal antibody (mAb) used in the present study, designated SC-72-14, was an immunoglobulin G 2 (IgG 2 ) antibody, that bound to eel electroplax membranes and rat brain synaptosomes (Meiri et al., 1984) . Its binding to both membrane preparations was inhibited by veratridine, augmented by scorpion toxin (leirus), but not altered by tetrodotoxin. It demonstrated immunofluorescent staining of the node of Ranvier, an action that was largely blocked by preincubation with veratridine and enhanced by scorpion toxin (Meiri et al., 1984) .
In some experiments, we used SC-72-14 in supernatant harvested from cells in tissue culture, and in others, in ascitic fluid. The IgG fraction of both sources was collected after precipitation by 40% ammonium sulfate and dialysis against saline. To determine whether constituents other than active mAb were responsible for the changes seen, we used two interventions. One was the inactive mAb SC-79-29. This was obtained from the same fusion experiments as SC-72-14 and was screened in parallel to SC-72-14. Unlike SC-72-14, however, it did not demonstrate immunofluorescent staining of the node of Ranvier; neither did it block the compound action potential. In still other experiments, we used mAb of clone SC-72-14 that had been boiled for 10 minutes.
To identify the concentrations of mAb used, we measured the absorbance of the undiluted supernatant of the hybridoma cultures at 280 nm to identify their total protein concentration. This was divided by a factor of 1.4, as an absorbance of 1.4 = 1 mg/ml of IgG (Davies et al., 1975) . Previous studies have shown that 1 % of the IgG fraction is mAb (Galfre and Milstein, 1981) . Therefore, the undiluted supernatant contained a mAb concentration of 50-100 Mg/rnl -This was diluted by 20 times in the tissue bath, such that the final mAb concentration in Tyrode's was 2.5-5 Mg/ml -The same procedure was used to identify the concentration of mAb in undiluted ascitic fluid. However, 50% of the IgG in ascitic fluid was mAb, and the final concentration in undiluted ascitic fluid was 0.5-1.0 mg/ ml. The dilution factor in the tissue bath again was 20 times.
Pharmacological Agents
We used commercially available xylocaine hydrochloride, manufactured by Astra Pharmaceutical.
Results

Effects of mAb, Alone, on the Transmembrane Potential and Membrane Responsiveness
The control transmembrane potentials from 17 Purkinje fiber bundles are presented in Table 1 , as Circulation Research/Vo/. 57, No. 3, September 1985 are their responses to mAb. The time-to-peak effect of the mAb was 10-20 minutes in group A and 5 -10 minutes in group B. There was no further effect with longer periods of superfusion, and a return to control transmembrane potential characteristics was seen within approximately 20 minutes after onset of washout.
In five experiments in which active mAb (SC-72-14) in ascitic fluid was used (Table 1A) , there was a significant reduction of VM, and the overshoot of the action potential, as well as an acceleration of repolarization. This was in contrast to the mAb in supernatant (SC-72-14) which signficantly reduced Vmax, only. However, higher concentrations of this mAb did decrease action potential amplitude while further reducing Vm^ (see Fig. 1 ).
Two forms of 'inactive* mAb were used. That of clone SC-79-29 (Table 1C) decreased maximum diastolic potential by 4 mV but had no significant effect on the other variables. The inactive mAb prepared by boiling SC-72-14 for 10 minutes was without effect on the transmembrane potential (Table ID). Representative transmembrane potentials are displayed in Figure 2 .
The effects of the active mAb, SC-72-14, on membrane responsiveness are presented in Figure 3 . Panel A shows the results of four experiments on fibers superfused with mAb in ascitic fluid, and panel B, in supernatant. Both mAb significantly depressed the membrane responsiveness curve (P < 0.05), but the slopes of the curves did not change (i.e., the depressed curves remained parallel to their controls). The membrane potential at which Vâ ttained 50% of its peak value did not change either; this was -77 mV for control and for mAb in ascitic = action potential duration to 50% and full repolarization; V^, = maximum rate of rise of phase 0.
• P < 0.05 cf control. 
Interactions of mAb and Lidocaine
The results reported here were for SC-72-14 in supernatant. Some experiments were done in ascitic fluid, as well, and gave the same results. The use- 
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Results are expressed as mean ± SE. Lido •» lidocaine.
• P < 0.05 cf control. t P < 0.05 cf control and AB.
value (panel A). In contrast, SC-72-14, alone, had no use-dependent effects (Fig. 4B ). Panel C shows the results of another experiment in which lidocaine evinced a use-dependent effect. Subsequent exposure to the SC-72-14 in the continued presence of lidocaine further reduced V,™^ but the use dependence no longer was seen. The experiment in Figure  4D demonstrates that the ability of the SC-72-14 to block the use-dependent effects of lidocaine is not simply a matter of reduction of V,^ by the lidocainemAb combination to a point where use dependence no longer can be seen. In this experiment, the effects on V^x of SC-72-14 plus lidocaine are shown at two different times. Note that the two curves "bracket' the curve seen with lidocaine, alone. In the BCL range < 400 msec, the mAb clearly did reduce the use-dependent effect of lidocaine on
These experiments suggested to us that SC-72-14 did have the capability of blocking the use-dependent effect of lidocaine. To document this further, we performed the sequence of experiments presented in Table 2 and Figures 5 and 6. Table 2 summarizes the effects of lidocaine and mAb on the transmembrane potential. One set of experiments was done with drive cycle lengths of 1000 and 400 msec; another set, with cycle lengths of 1500 and 500 msec. Note that in both types of experiment the only effect of SC-72-14, alone, was on V^,. The addition of lidocaine to SC-72-14 resulted in reduction of the maximum diastolic potential and duration of the action potential, as well as a further reduction of 
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V, (V/sec) 800 700 600 500 400 X A. * X ** Figure 5 summarizes four experiments in which Purkinje fibers were driven at cycle lengths of 1000 and then 400 msec during control, and then were exposed to SC-72-14 alone, followed by mAb plus lidocaine. Activation voltage was maintained constant during these experiments (control = -88 ± 1 mV; SC-72-14 = -88 ± 1 mV; lido + SC-72-14 = -87 ± 1 mV). During control, there was no change in V. MX as a result of changing drive cycle length. In the presence of SC-72-14, V^ was reduced significantly (P < 0.05) from control at a drive cycle length of 1000 msec, and did not change further at a cycle length of 400 msec. With SC-72-14 plus lidocaine, there was a further reduction of V^^ at the drive cycle length of 1000 msec (P < 0.05). Shortening the drive cycle length to 400 msec induced no further change. SC-72-14, alone, reduced V,^ by 15% from control. Lidocaine plus SC-72-14 resulted in an additional 8% reduction of V,,^ (P < 0.05).
In Figure 6 , the sequence of experiments was reversed. Following control, four preparations were exposed to lidocaine, alone, followed by lidocaine plus SC-72-14. Here, too, activation voltage was constant (-87±2 mV, throughout). During control there was no difference in Vma* at drive cycle lengths of 1000 and 400 msec. Lidocaine, alone, reduced V™, by 9% at a cycle length of 1000 msec (P < 0.05), and changing the drive cycle length to 400 msec reduced V mtx by another 7% (P < 0.05). Addition of SC-72-14 to the lidocaine decreased V,™ by 16% from the value seen with lidocaine alone (P < 0.05). However, changing the cycle length to 400 msec now induced no further change. A representative experiment is presented in Figure 7 .
Discussion
The preceding experiments have demonstrated (1) the ability of a monoclonal antibody, SC-72-14, to depress the Vm^ of the canine Purkinje fiber trans- membrane potential, (2) the lack of any use-dependent effect of SC-72-14 over the range of cycle lengths studied, and (3) the suppression of the usedependent actions of the local anesthetic, lidocaine, by SC-72-14. When we consider these results, two questions immediately arise. First, can the actions of SC-72-14 be considered as a specific result of binding to an antigen near or in the fast channel? Second, what is the basis for the interaction of SC-72-14 with lidocaine? In considering the answers to these questions, we must bear in mind that the measurement of Vow does not permit a quantitative discussion of the Na + channel; however, it does permit us to make certain deductions about the effects of antibody and/or drug (see Gintant et al., 1983a; Grant et al., 1984) .
With respect to the first question, previous studies have demonstrated the binding of SC-72-14 to eel electroplax membranes and rat brain synaptosomes, its immunofluorescent staining of the node of Ranvier, and its block of the compound action potentials of rat optic and sciatic nerve (Meiri et al., 1984) . Moreover, voltage clamp studies have shown a shift of the steady state inactivation (h») curve toward hyperpolarization as well as a reduction of activation (rru, or gNa) (Meiri et al., unpublished data) . In the present study, the action of SC-72-14 in ascitic fluid was such that not only were Vm^ membrane responsiveness, and the amplitude of the Purkinje fiber action potential reduced, but the plateau was depressed and repolarization was accelerated, as well. In contrast, SC-72-14, in supernatant reduced Vm« and membrane responsiveness only. These observations suggested to us that other factors present in the ascitic fluid might have been responsible for some of the changes seen with this vehicle. In fact, subsequent experiments using another batch of SC-72-14 in ascitic fluid have shown no effect on repolarization, with a persistent effect on Vn,^ comparable to that described here.
One might suggest that substances in the supernatant other than the active mAb were responsible for the reduction of Vm^, and membrane responsiveness. That this is not the case is suggested by the experiments in Table 1 and Figure 2 , which demonstrate that both the 'inactive* mAb and the boiled active mAb in supernatant (SC-72-14) do not exert any effects on V™.
Given the probable size of the mAb molecule, about 150 A (Meiri et al., unpublished data) , it is unlikely that it binds to sites deep within the cell membrane (i.e., at, or deep, to the level of the 'selectivity filter*). As a result of its binding to a site on the membrane, SC-72-14 might be expected to impede Na + entry by modifying the structure of the channel, the charge on the membrane, the number of available channels, and/or the function of the mor h-gates (Meiri et al., unpublished data) . That an effect on the h-gate is less likely is suggested by the failure of SC-72-14 to alter repolarization. However, such a conclusion is tentative, and requires confir-mation by voltage clamp studies.
Before discussing the interactions of SC-72-14 with lidocaine, it is reasonable to question whether the mAb or other proteins in the supernatant might bind to the drug, thereby reducing its ability to gain access to the membrane. That this is not the case is suggested by reviewing the tonic blocking effects of lidocaine shown in Figures 5 and 6 . In the absence of SC-72-14 (Fig. 6) , lidocaine reduced V™, by 9% at a drive cycle length of 1000 msec. In the set of experiments summarized in Figure 5 , SC-72-14 was present prior to lidocaine. If there had been a significant concentration of lidocaine-binding proteins in the supernatant, they would have had the opportunity to bind to lidocaine in this setting. Nonetheless, in the presence of SC-72-14, lidocaine still reduced Va^x by 8%. Hence, there is no evidence for significant interference by SC-72-14 with lidocaine's ability to induce tonic block as tested using V^. The reverse is true as well: SC-72-14, alone, reduced Vmax by 15% (Fig. 5 ). On pretreatment with lidocaine, SC-72-14 reduced V™ by 16% (Fig. 6) .
In sum, neither lidocaine nor SC-72-14 modified the other's ability to induce tonic block. That the two agents also demonstrated a tonic-blocking action equal to the sum of each agent alone suggests that lidocaine and SC-72-14 may not share a common binding site, and that they do not impede one another's access to their respective binding sites.
There are several possible means whereby SC-72-14 may modify the use-dependent effects of lidocaine. Review of the literature on use dependence (e.g., Strichartz, 1973; Courtney, 1975 Courtney, , 1980 Hille, 1977a Hille, , 1977b Katzung, 1977, 1980; Grant et al., 1984) suggests that the affinity of the receptor for un-ionized and ionized forms of drug will change with the channel state. The fact that the use-dependent effects of lidocaine are diminished in the presence of SC-72-14 suggests that the increased channel patency that is required for lidocaine to exert its use-dependent action might be altered by the mAb. In addition to such a change in channel state, SC-72-14 might induce a change in receptor affinity for the drug. It may be, as well, that the 'unbinding' of lidocaine from its receptor occurs more readily in the presence of SC-72-14, a factor that would tend to reduce its use-dependent effects. Still another possibility is that SC-72-14 modifies surface charge and/or ionization of lidocaine, thereby limiting the availability of ionized drug to receptor sites. These possibilities all await further testing.
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